)
Vir Biotechnology (VIR) investor relations material
Vir Biotechnology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 26, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 25, 2026, 11:59 PM ET.
Voting matters and shareholder proposals
Election of three directors: Robert More, Janet Napolitano, and Elliott Sigal, each to serve until the 2029 annual meeting.
Advisory vote to approve compensation of named executive officers.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Three director nominees presented for election, each with specified professional credentials.
Directors to serve three-year terms, subject to earlier death, resignation, or removal.
- Director elections, executive pay, and auditor ratification headline a governance-focused agenda.VIR
Proxy filing16 Apr 2026 - Astellas deal, strong VIR-5500 data, and licensing boost cash and pipeline for 2027 trials.VIR
Q4 202511 Apr 2026 - Strong clinical data and partnerships drive rapid progress in oncology and hepatitis delta.VIR
Leerink Global Healthcare Conference 202610 Mar 2026 - VIR-5500 delivers best-in-class efficacy and safety, driving expansion and pivotal trials in 2025.VIR
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - CHD therapy and masked TCEs show strong efficacy, safety, and value-driving milestones ahead.VIR
Corporate presentation23 Feb 2026 - Durable HDV responses and a robust pipeline drive progress toward key milestones.VIR
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Q2 net loss narrowed to $138.4M as restructuring and Sanofi deal sharpen focus on hepatitis and T-cell assets.VIR
Q2 20242 Feb 2026 - Tobevibart and elebsiran show strong efficacy and safety in chronic hepatitis delta patients.VIR
Study Update31 Jan 2026 - Strategic refocus on immune therapies and T-cell engagers, with major clinical data due in the next year.VIR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
Next Vir Biotechnology earnings date
Next Vir Biotechnology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage